You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API FELBAMATE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing FELBAMATE

Company Ingredient NDC Excipient
Pharmaceutical Associates Inc felbamate 0121-0891 CARBOXYMETHYLCELLULOSE SODIUM
Pharmaceutical Associates Inc felbamate 0121-0891 CELLULOSE, MICROCRYSTALLINE
Pharmaceutical Associates Inc felbamate 0121-0891 CITRIC ACID MONOHYDRATE
Pharmaceutical Associates Inc felbamate 0121-0891 DIMETHICONE
Pharmaceutical Associates Inc felbamate 0121-0891 FD&C RED NO. 40
Pharmaceutical Associates Inc felbamate 0121-0891 FD&C YELLOW NO. 6
Pharmaceutical Associates Inc felbamate 0121-0891 GLYCERIN
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for FELBAMATE

Excipient focus: ALUMINUM OXIDE

Excipient focus: BENZOIC ACID

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIMETHICONE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GLYCERIN

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLPARABEN

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE K30

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM

Excipient focus: SACCHARIN SODIUM MONOHYDRATE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

FELBAMATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Pharmaceutical Associates Inc felbamate 0121-0891
Marlex Pharmaceuticals Inc felbamate 10135-601
NORTHSTAR RX LLC felbamate 16714-775
Alvogen Inc felbamate 47781-627
Taro Pharmaceuticals USA Inc felbamate 51672-4172
Taro Pharmaceuticals USA inc felbamate 51672-4185
Amneal Pharmaceuticals of New York LLC felbamate 53746-734
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SORBIC ACID

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: SUCRALOSE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group